New Weight-Loss shot tested in humans for first time
NCT ID NCT06737536
First seen Sep 30, 2025 · Last updated May 24, 2026 · Updated 29 times
Summary
This study tested a new injectable medicine, NNC0662-0419, in 100 adults with overweight or obesity. The main goal was to check its safety and how the body processes it, as this was the first time it was given to humans. Participants received either the study drug or a placebo over about 9 months. The results will help determine if further studies are warranted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Celerion, Lincoln
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.